The Integration of the Glutamatergic and the White Matter Hypotheses of Schizophrenia's Etiology

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|10|1|2-11

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.10, Iss.1, 2012-03, pp. : 2-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamatergic Animal Models of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1593-1604

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

By Heresco-Levy Uriel  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 827-844

Informa Healthcare

Access to resources Recommend Favorite

Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 26-54

Bentham Science Publishers

Access to resources Recommend Favorite

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

By  

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 219-238

Bentham Science Publishers

Access to resources Recommend Favorite

From Glutamatergic Dysfunction to Cognitive Impairment: Boundaries in the Therapeutic of the Schizophrenia

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1543-1548

Bentham Science Publishers

Access to resources Recommend Favorite